Yuan-fang F. Li
651 East Dongfeng Road
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Adjuvant oxaliplatin with S-1 (SOX) versus S-1 for stage II-III gastric cancer (CAPITAL): A randomized, open-label, phase 3 trial.
Journal: Med (New York, N.Y.)
Published: April 02, 2026
Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancer.
Journal: Cell reports. Medicine
Published: January 14, 2025
ALKBH5 suppresses gastric cancer tumorigenesis and metastasis by inhibiting the translation of uncapped WRAP53 RNA isoforms in an m6A-dependent manner.
Journal: Molecular cancer
Published: October 26, 2024
Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: September 18, 2023
Surrogate Endpoints for Overall Survival in Immune-Oncology Trials of Advanced Gastro-Esophageal Carcinoma.
Journal: World journal of oncology
Published: March 31, 2022
Correction to: Adjuvant Chemotherapy for Gastric Cancer Patients with Mismatch Repair Deficiency or Microsatellite Instability: Systematic Review and Meta-Analysis.
Journal: Annals of surgical oncology
Published: December 07, 2021
ASO Author Reflections: Adjuvant Chemotherapy Should not be Omitted for Gastric Cancer Patients with Mismatch Repair Deficiency or Microsatellite Instability.
Journal: Annals of surgical oncology
Published: October 18, 2021
Adjuvant Chemotherapy for Gastric Cancer Patients with Mismatch Repair Deficiency or Microsatellite Instability: Systematic Review and Meta-Analysis.
Journal: Annals of surgical oncology
Published: July 08, 2021
Cancer cells invasion to the gastric bare area adipose tissue: a poor prognostic predictor for gastric cancer.
Journal: World journal of surgical oncology
Published: August 11, 2020
Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials.
Journal: BMC cancer
Published: August 08, 2019
Last Updated: 09/26/2026